Works matching IS 19466234 AND DT 2022 AND VI 14 AND IP 634

Results: 6

Antibodies elicited by SARS-CoV-2 infection or mRNA vaccines have reduced neutralizing activity against Beta and Omicron pseudoviruses.
Published in:
Science Translational Medicine, 2022, v. 14, n. 634, p. 1, doi. 10.1126/scitranslmed.abn7842
By:
- Sievers, Benjamin L.;
- Chakraborty, Saborni;
- Xue, Yong;
- Gelbart, Terri;
- Gonzalez, Joseph C.;
- Cassidy, Arianna G.;
- Golan, Yarden;
- Prahl, Mary;
- Gaw, Stephanie L.;
- Arunachalam, Prabhu S.;
- Blish, Catherine A.;
- Boyd, Scott D.;
- Davis, Mark M.;
- Jagannathan, Prasanna;
- Nadeau, Kari C.;
- Pulendran, Bali;
- Singh, Upinder;
- Scheuermann, Richard H.;
- Frieman, Matthew B.;
- Vashee, Sanjay
Publication type:
Article
Pathogenic variants in MDFIC cause recessive central conducting lymphatic anomaly with lymphedema.
Published in:
Science Translational Medicine, 2022, v. 14, n. 634, p. 1, doi. 10.1126/scitranslmed.abm4869
By:
- Byrne, Alicia B.;
- Brouillard, Pascal;
- Sutton, Drew L.;
- Kazenwadel, Jan;
- Montazaribarforoushi, Saba;
- Secker, Genevieve A.;
- Oszmiana, Anna;
- Babic, Milena;
- Betterman, Kelly L.;
- Brautigan, Peter J.;
- White, Melissa;
- Piltz, Sandra G.;
- Thomas, Paul Q.;
- Hahn, Christopher N.;
- Rath, Matthias;
- Felbor, Ute;
- Korenke, G. Christoph;
- Smith, Christopher L.;
- Wood, Kathleen H.;
- Sheppard, Sarah E.
Publication type:
Article
A carcinoembryonic antigen-specific cell therapy selectively targets tumor cells with HLA loss of heterozygosity in vitro and in vivo.
Published in:
Science Translational Medicine, 2022, v. 14, n. 634, p. 1, doi. 10.1126/scitranslmed.abm0306
By:
- Sandberg, Mark L.;
- Wang, Xueyin;
- Martin, Aaron D.;
- Nampe, Daniel P.;
- Gabrelow, Grant B.;
- Li, Chuck Z.;
- McElvain, Michele E.;
- Lee, Wen-Hua;
- Shafaattalab, Sanam;
- Martire, Sara;
- Fisher, Fernando A.;
- Ando, Yuta;
- Liu, Edwin;
- Ju, David;
- Wong, Lu Min;
- Xu, Han;
- Kamb, Alexander
Publication type:
Article
SERAC1 is a component of the mitochondrial serine transporter complex required for the maintenance of mitochondrial DNA.
Published in:
Science Translational Medicine, 2022, v. 14, n. 634, p. 1, doi. 10.1126/scitranslmed.abl6992
By:
- Fang, Hezhi;
- Xie, Anran;
- Du, Miaomiao;
- Li, Xueyun;
- Yang, Kaiqiang;
- Fu, Yinxu;
- Yuan, Xiangshu;
- Fan, Runxiao;
- Yu, Weidong;
- Zhou, Zhuohua;
- Sang, Tiantian;
- Nie, Ke;
- Li, Jin;
- Zhao, Qiongya;
- Chen, Zhehui;
- Yang, Yanling;
- Hong, Chaoyang;
- Lyu, Jianxin
Publication type:
Article
Modeling injury and repair in kidney organoids reveals that homologous recombination governs tubular intrinsic repair.
Published in:
Science Translational Medicine, 2022, v. 14, n. 634, p. 1, doi. 10.1126/scitranslmed.abj4772
By:
- Gupta, Navin;
- Matsumoto, Takuya;
- Hiratsuka, Ken;
- Garcia Saiz, Edgar;
- Galichon, Pierre;
- Miyoshi, Tomoya;
- Susa, Koichiro;
- Tatsumoto, Narihito;
- Yamashita, Michifumi;
- Morizane, Ryuji
Publication type:
Article
Modeling genetic diseases in nonhuman primates through embryonic and germline modification: Considerations and challenges.
Published in:
Science Translational Medicine, 2022, v. 14, n. 634, p. 1, doi. 10.1126/scitranslmed.abf4879
By:
- Schmidt, Jenna K.;
- Jones, Kathryn M.;
- Van Vleck, Trevor;
- Emborg, Marina E.
Publication type:
Article

Works matching IS 19466234 AND DT 2022 AND VI 14 AND IP 634

Antibodies elicited by SARS-CoV-2 infection or mRNA vaccines have reduced neutralizing activity against Beta and Omicron pseudoviruses.

Pathogenic variants in MDFIC cause recessive central conducting lymphatic anomaly with lymphedema.

A carcinoembryonic antigen-specific cell therapy selectively targets tumor cells with HLA loss of heterozygosity in vitro and in vivo.

SERAC1 is a component of the mitochondrial serine transporter complex required for the maintenance of mitochondrial DNA.

Modeling injury and repair in kidney organoids reveals that homologous recombination governs tubular intrinsic repair.

Modeling genetic diseases in nonhuman primates through embryonic and germline modification: Considerations and challenges.